The Effects of GABA on embryonic gonadotropin-releasing hormone neurons in rat hypothalamic primary culture.
Gonadotropin-releasing hormone (GnRH) neurons arise in the olfactory placode, migrate into the preoptic area (POA), and then extend axons to the median eminence during embryogenesis. Little information is available concerning the properties of GnRH neurons during the late gestational period when GnRH neurons reach the POA and form neuronal networks, although many studies have examined such properties during earlier developmental stages or the postnatal period. The present study was performed to elucidate the involvement of gamma-aminobutyric acid (GABA), one of the major neurotransmitters modifying GnRH neural activity, in regulation of GnRH gene expression on embryonic day 18.5 (E18.5) using transgenic rats expressing enhanced green fluorescence protein (EGFP) under the control of GnRH promoter. First, using RT-PCR, the mRNA of two isoforms of the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD), GAD65 and GAD67 was detected in E18.5 embryonic POA-containing tissues. GAD67-positive cells were also demonstrated in close vicinity to GnRH-positive cells by immunohistochemistry, and immunoreactivity for both the GABA-A and GABA-B receptor subunits was detected in GnRH neurons. Next, primary cultures derived from anterior hypothalamic tissue of E18.5 embryos were prepared, and the effects of GABA and its agonists on GnRH promoter activity were evaluated using EGFP expression as a marker. GABA and the GABA-A receptor agonist muscimol, but not the GABA-B receptor agonist baclofen, significantly increased the EGFP-positive/GnRH-positive cell ratio. These results suggest that GABA plays a role in stimulating GnRH gene expression through GABA-A receptors in embryonic GnRH neurons in late gestational stages.
Fujioka
Hitomi
H
Department of Veterinary Physiology, Veterinary Medical Science, The University of Tokyo, Tokyo, Japan.
Yamanouchi
Keitaro
K
Akema
Tatsuo
T
Nishihara
Masugi
M
D000818:Animals; D030801:Animals, Genetically Modified; D002478:Cells, Cultured; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D005968:Glutamate Decarboxylase / Q000235:genetics; D007987:Gonadotropin-Releasing Hormone / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D049452:Green Fluorescent Proteins / Q000235:genetics; D007031:Hypothalamus / Q000187:drug effects* / Q000196:embryology*; D007527:Isoenzymes / Q000235:genetics; D009474:Neurons / Q000187:drug effects*; D011188:Potassium / Q000494:pharmacology; D011301:Preoptic Area / Q000196:embryology; D051381:Rats; D017208:Rats, Wistar; D018079:Receptors, GABA / Q000235:genetics; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology*
D007527:Isoenzymes; D018079:Receptors, GABA; D049452:Green Fluorescent Proteins; D007987:Gonadotropin-Releasing Hormone; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase; D011188:Potassium